Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors: An Update

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.3, 2002-01, pp. : 207-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors

By Jann M.W.

Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. : 719-739

Adis International

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil Lip Gregory YH

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptide Inhibitors of Thermolysin and Angiotensin I-Converting Enzyme

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 16, 2012-08 ,pp. : 1748-1762

Bentham Science Publishers

Access to resources Recommend Favorite